BioSpace News Archive

DataTribe, a global cyber foundry that creates and co-builds next-generation cybersecurity and data science companies with nation-state experienced technical teams from the intelligence community and research labs announced the addition of two startup experts to their team.

Postpartum depression is the most common medical complication of childbirth, estimated to affect approximately 400,000 women annually in the U.S.

Physicians from several study sites involved in CalciMedica’s initial acute pancreatitis clinical study of its CRAC channel inhibitor CM4620 and CalciMedica, Inc., presented a poster at the 39th International Symposium on Intensive Care and Emergency Medicine being held in Brussels on March 19-22.

Digipath, Inc. is pleased to announce that it is the featured company in the most recent edition of CANNAINVESTOR Magazine, with comprehensive coverage of the Company’s business model and accomplishments.

The Genio® system is the world’s first and only battery-free, leadless and minimally invasive neurostimulator, capable of delivering bilateral hypoglossal nerve stimulation for moderate to severe OSA patients who have failed conventional Positive Airway Pressure (PAP) therapy.

Designation Recognizes Medela’s Commitment to Supporting Every Moms’ Breastfeeding Journey

Mr. Engelson brings three decades of medical device innovation and commercialization experience.

Salix Pharmaceuticals will present scientific research, including data from three abstracts at Hospital Medicine 2019, the annual conference of the Society of Hospital Medicine, being held in National Harbor, Md., March 24-27, 2019.

The Angiogenesis Foundation announced the publication of EAT TO BEAT DISEASE – The New Science of How Your Body Can Heal Itself authored by its CEO and President, Dr. William W. Li.

Hoffmann-La Roche Limited announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for a Letter of Intent regarding OCREVUS® for the first-line treatment of adult patients with relapsing remitting multiple sclerosis with active disease, and for the management of adult patients with early primary progressive multiple sclerosis.